[dekhn]

QC and regulatory costs are absolutely borne by the corporations that are getting their drugs approved. Those are major expenditures.

I'm not completely arguing with the idea that pharma overprices drugs, but to me, that's a distinct problem from who pays for, and benefits from research and development.